Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
14 hours ago • Google News
Novavax Inc (NVAX)
US$ 7.4819.68%
Price Chart
Key Statistics
Market Cap
$ 1.2B
P/E Ratio
0.00
Revenue (TTM)
$ 682.16M
Volume
14.04M
52W High
$ 23.86
52W Low
$ 3.92
Dividend Yield
0.00%
Beta
3.14
Technicals
50-Day MA
7.2958
200-Day MA
9.9654
52 Week High
23.8599
52 Week Low
3.92
About NVAX
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internatio.
Employees
952
Headquarters
Gaithersburg, MD
CEO
Mr. John Charles Jacobs M.B.A.
Latest News
Novavax (NVAX) Rises Amid FDA Data Request for COVID-19 Vaccine - GuruFocus
16 hours ago • Google News
$NVAX stock is up 17% today. Here's what we see in our data. - Nasdaq
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg